Blake v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Mark Allan Blake |
| Chattem, Inc., Sanofi US Services Inc., Pfizer, Inc., GlaxoSmithKline, LLC and Boehringer Ingelheim Pharmaceuticals, Inc. |
| 1:2019cv02991 |
| October 21, 2019 |
| US District Court for the District of Colorado |
| Michael E Hegarty |
| Tort Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 21, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Administrative Notice: Duplicate filing fee received. Financial notified and a refund is pending. (Text Only Entry) (rsams, ) |
| Filing 1 COMPLAINT against All Defendants (Filing fee $ 400,Receipt Number 1082-6954445)Attorney Robert Brent Wisner added to party Mark Allan Blake(pty:pla), filed by Mark Allan Blake. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Wisner, Robert) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Colorado District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
